FFFMX
Price
$64.27
Change
+$0.34 (+0.53%)
Updated
Sep 11 closing price
Net Assets
117.47B
MDDAX
Price
$9.90
Change
+$0.05 (+0.51%)
Updated
Sep 11 closing price
Net Assets
471.04M
Interact to see
Advertisement

FFFMX vs MDDAX

FFFMX vs MDDAX Comparison Chart in %
View a ticker or compare two or three
VS
FFFMX vs. MDDAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFFMX is a Buy and MDDAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFFMX has more cash in the bank: 117B vs. MDDAX (471M). FFFMX pays higher dividends than MDDAX: FFFMX (1.66) vs MDDAX (1.10). FFFMX was incepted earlier than MDDAX: FFFMX (6 years) vs MDDAX (22 years). MDDAX (1.10) is less costly to investors than FFFMX (0.32). MDDAX is a more actively managed with annual turnover of: 68.00 vs. FFFMX (30.00). FFFMX has a lower initial minimum investment than MDDAX: FFFMX (250) vs MDDAX (1000). MDDAX annual gain was more profitable for investors over the last year : 21.07 vs. FFFMX (5.44). FFFMX return over 5 years is better than : 39.87 vs. MDDAX (-21.85).
FFFMXMDDAXFFFMX / MDDAX
Total Expense Ratio0.321.1029%
Annual Report Gross Expense Ratio0.321.1029%
Fund Existence6 years22 years-
Gain YTD8.99518.26949%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B471M24,841%
Annual Yield % from dividends1.661.10151%
Returns for 1 year5.4421.0726%
Returns for 3 years37.95-9.16-415%
Returns for 5 years39.87-21.85-183%
Returns for 10 yearsN/A-21.33-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBGLX27.430.25
+0.92%
Bridge Builder Large Cap Growth
AVDNX17.850.13
+0.73%
Avantis® International Equity G
VCSTX46.89N/A
N/A
VALIC Company I Science & Technology
SPGRX24.72N/A
N/A
DWS Equity Sector Strategy Fund Class S
VREMX7.73N/A
N/A
Virtus SGA Emerging Markets Equity R6